ロード中...
Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2012-12-01
|
| シリーズ: | BMC Cancer |
| 主題: | |
| オンライン･アクセス: | http://www.biomedcentral.com/1471-2407/12/587 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|